DoctorDirectory.ai
Menu

Dr. Rajesh Mohandas, MD

Not yet claimed

Nephrologist · Physician (MD)

New Orleans, LA

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you Rajesh Mohandas? Claim this profile.

Dr. Rajesh Mohandas is a kidney specialist on the nephrology faculty at LSU Health in New Orleans. He is listed as part of the medical school's nephrology section.

About Dr. Rajesh Mohandas, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. Rajesh Mohandas is a kidney specialist (nephrologist) in New Orleans. He is an Associate Professor of Medicine and Chief of the Section of Nephrology and Hypertension at LSU Health Sciences Center New Orleans. He joined LSUHSC and University Medical Center New Orleans in March 2022 after more than ten years on the faculty at the University of Florida.

His clinical focus is high blood pressure (hypertension) and chronic kidney disease. He earned his medical degree from the University of Kerala / Medical College Thiruvananthapuram in 1994, completed internal medicine residency at Westchester Medical Center, and finished a nephrology fellowship at the University of Florida in 2011.

He is also a physician-scientist who runs a research laboratory studying the blood vessel biology of kidney disease. His academic profile lists about 79 publications with roughly 905 citations, and he has held an NIH K08 research award. He publishes with trainees, including LSU internal medicine residents and postdoctoral fellows.

Public records from CMS Open Payments show $3,533.28 in industry payments across 99 records from 2021 to 2025, with the largest amounts from Amgen, Otsuka, GlaxoSmithKline, and Fresenius. Payments of this kind are common and legal, and are often things like meals at educational events.

Section chief at LSU
He is Associate Professor of Medicine and Chief of the Section of Nephrology and Hypertension at LSU Health Sciences Center New Orleans, a role he has held since 2022. medschool.lsuhsc.edu
Focus on blood pressure and CKD
His listed clinical focus is hypertension and chronic kidney disease. At the University of Florida he directed the Hypertension Clinic. medschool.lsuhsc.edu
Nephrology fellowship training
He completed his nephrology fellowship at the University of Florida from 2008 to 2011, supported by an NIH T32 training grant. medschool.lsuhsc.edu
Research and NIH funding
He runs a laboratory studying the small blood vessels in kidney disease and acknowledged an NIH K08 award (HL130945) in a 2021 publication. onlinelibrary.wiley.com
About 79 publications
His academic profile lists roughly 79 publications and about 905 citations, including papers in JASN, Microcirculation, and the American Journal of Nephrology. researchgate.net
Fellow of nephrology society
His official faculty page lists the credential FASN, Fellow of the American Society of Nephrology. medschool.lsuhsc.edu
Teaches and mentors trainees
He has co-authored research with LSU internal medicine residents and mentors postdoctoral fellows whose work has been presented at American Heart Association Scientific Sessions. medschool.lsuhsc.edu
Industry payments 2021-2025
CMS Open Payments records show $3,533.28 across 99 records, with top payers Amgen ($714.53), Otsuka ($359.06 and $227.80), GlaxoSmithKline ($264.94), and Fresenius ($215.89). openpaymentsdata.cms.gov

Worth knowing

  • Board certification could not be confirmed in this research. Patients can check certification directly at certificationmatters.org. certificationmatters.org
  • Some online directories still list a Gainesville, Florida address or UF Health Shands affiliation, which reflects his previous position rather than his current practice in New Orleans. nephrology.medicine.ufl.edu
  • Mentions of a 2025 LSU faculty service recognition and a 2025 Lewis K. Dahl Memorial Lecture appeared in a LinkedIn feed snippet, but the research could not confirm these awards from an independent source. linkedin.com

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$3,533

99 payments

2021$0
2022$695
2023$731
2024$738
2025$1,369

Top payers

  • Amgen Inc.$715
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$359
  • GlaxoSmithKline, LLC.$265
  • Otsuka America Pharmaceutical, Inc.$228
  • Fresenius USA Marketing, Inc.$216

Payment types

  • Food and Beverage$3,435
  • Education$99

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: medschool.lsuhsc.edu · nephrology.medicine.ufl.edu · bsky.app · linkedin.com · researchgate.net · doximity.com · doctor.webmd.com · health.usnews.com. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

Something wrong with this profile? ·